Home › Asset managers › Compare 2024-2025 › BlackRock vs Charles Schwab
BlackRock 2024-2025 · Charles Schwab 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 9,052 | 8,435 | 409 | 208 | 95.4% | 94.7% |
| Board proposals | 7,754 | 7,281 | 321 | 152 | 95.8% | 95.2% |
| E&S shareholder proposals | 252 | 217 | 5 | 30 | 97.7% | 96.3% |
| Other items | 1,046 | 937 | 83 | 26 | 91.9% | 90.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
473 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Charles Schwab |
|---|---|---|---|---|---|---|
| 3D SYSTEMS CORP. | August 30, 2024 | The approval of the amendment and restatement of the 2015 Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 4,000,000 shares. Compensation |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| ACELYRIN INC. | May 13, 2025 | To adopt the Agreement and Plan of Merger, dated February 6, 2025, among Alumis Inc., Arrow Merger Sub, Inc. and ACELYRIN, Inc., as may be amended from time to time. We refer to this proposal as the "ACELYRIN merger proposal." Extraordinary Transactions |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| ADICET BIO INC. | June 11, 2025 | To ratify, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ADVERUM BIOTECHNOLOGIES INC. | June 17, 2025 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share as described in the Proxy Statement (as supplemented). Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| AERCAP HOLDINGS N.V. | April 16, 2025 | Re-appointment of Mr. Paul Dacier as non-executive director for a period of four years. Director Elections |
Board | For | AGAINST 21 funds |
FOR 6 funds |
| AEROVATE THERAPEUTICS INC. | April 16, 2025 | Redomestication Proposal - To approve the redomestication of Aerovate from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| AGENUS INC. | June 17, 2025 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| AIRGAIN INC | June 11, 2025 | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ALIMERA SCIENCES INC. | September 4, 2024 | To approve, by non-binding, advisory vote, the compensation that will or may be paid or become payable to our named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| ALTI GLOBAL INC. | June 16, 2025 | To approve an amendment to the Company's 2023 Stock Incentive Plan to increase the number of shares of Class A Common Stock available for issuance under the Company's 2023 Stock Incentive Plan and the number of shares that may be issued pursuant to incentive stock options by an additional 9,010,000 shares. Compensation |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| ALTO NEUROSCIENCE INC. | May 13, 2025 | Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders: Husseini Manji Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 2 funds |
| AMC NETWORKS INC | June 5, 2025 | Advisory vote on Named Executive Officer compensation Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 8 funds |
| AMERICAN INTERNATIONAL GROUP INC. | May 14, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 58 funds |
AGAINST 14 funds |
| AMERISERV FINANCIAL INC. | August 20, 2024 | An advisory vote to approve the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| AMN HEALTHCARE SERVICES INC. | May 2, 2025 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 8 funds |
| AMPHENOL CORP. | May 15, 2025 | Approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock Capital Structure |
Board | For | FOR 52 funds |
AGAINST 14 funds |
| AMYLYX PHARMACEUTICALS INC. | June 5, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 4 funds |
| ANAPTYSBIO INC. | June 17, 2025 | To approve an amendment to our 2017 Equity Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 3 funds |
| ANTERO RESOURCES CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 44 funds |
AGAINST 13 funds |
| API GROUP | May 16, 2025 | To approve the amendment of our certificate of incorporation to increase the number of authorized shares of common stock. Capital Structure |
Board | Not determined | FOR 18 funds |
AGAINST 12 funds |
| APPLIED DIGITAL CORP. | November 20, 2024 | Approve an amendment to the Company's Second Amended and Restated Articles of Incorporation, as amended, to increase the number of shares of common stock and the number of shares of preferred stock authorized for issuance thereunder. Capital Structure |
Board | For | FOR 9 funds |
AGAINST 4 funds |
| ARBOR REALTY TRUST INC. | May 21, 2025 | Advisory vote to approve the compensation of Arbor Realty Trust, Inc.'s named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 8 funds |
| ARCA BIOPHARMA, INC. | August 22, 2024 | Election of Director: Mr. Jacob Ma-Weaver Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| ARCELLX INC. | May 28, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | FOR 35 funds |
AGAINST 6 funds |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 24 funds |
AGAINST 5 funds |
| ARDAGH METAL PACKAGING S.A. | May 27, 2025 | Elect Stefan Schellinger, as a Class II Director until the 2026 annual general meeting of shareholders. Director Elections |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| ARDAGH METAL PACKAGING S.A. | May 27, 2025 | Re-elect Damien O'Brien, as a Class I Director until the 2028 annual general meeting of shareholders. Director Elections |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| ARDAGH METAL PACKAGING S.A. | May 27, 2025 | Re-elect Yves Elsen, as a Class I Director until the 2028 annual general meeting of shareholders. Director Elections |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| ARLO TECHNOLOGIES INC. | June 20, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 6 funds |
| ARM HOLDINGS PLC | September 11, 2024 | To approve the rules of the Arm Holdings plc Employee Stock Purchase Plan 2024 (the "ESPP"), the principal features of which are summarised in the Appendix to this Notice of Annual General Meeting and that the directors of the Company be authorised to take such actions as may be necessary to facilitate the implementation of the ESPP. Compensation |
Board | None | FOR 7 funds |
AGAINST 2 funds |
| ARRAY TECHNOLOGIES INC. | May 20, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 7 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 39 funds |
AGAINST 5 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Director: Douglas Ingram Director Elections |
Board | For | FOR 24 funds |
AGAINST 4 funds |
| ARVINAS INC. | June 25, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 5 funds |
| ASPEN AEROGELS INC. | April 30, 2025 | Approval of the Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 4 funds |
| ASSURED GUARANTY LTD. | May 2, 2025 | Advisory vote on the compensation paid to the Company's named executive officers Say-on-Pay |
Board | For | FOR 40 funds |
AGAINST 9 funds |
| ASTRANA HEALTH INC. | June 11, 2025 | To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 8 funds |
| ASURE SOFTWARE INC. | June 2, 2025 | To approve an amendment to the Asure Software, Inc. 2018 Incentive Award Plan to increase the number of shares of our common stock authorized for issuance by 2,250,000 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ATLANTICUS HOLDINGS CORP. | May 8, 2025 | To approve the "say-on-pay" resolution set forth below: RESOLVED, that the shareholders of Atlanticus Holdings Corporation hereby approve, on an advisory basis, the compensation of the company's named executive officers, as disclosed in the company's Proxy Statement for the 2025 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Summary Compensation Table and the other related tables and disclosure. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 3 funds |
| ATOMERA INC. | May 15, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| ATRICURE INC. | May 19, 2025 | Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 6 funds |
| AVID BIOSERVICES INC. | January 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Avid's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contentemplated by the Merger Agreement. Say-on-Pay |
Board | For | FOR 21 funds |
AGAINST 5 funds |
| AVITA MEDICAL INC. | June 4, 2025 | To approve the grant of 520,000 options to acquire shares of Common Stock to the Company's Chief Executive Officer, James Corbett, on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| AXOGEN INC. | June 19, 2025 | To approve the Axogen, Inc. Fourth Amended and Restated 2019 Long-Term Incentive Plan to increase the number of shares authorized for issuance thereunder from 10,500,000 to 13,400,000. Compensation |
Board | For | FOR 15 funds |
AGAINST 5 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Adriane Brown Director Elections |
Board | For | FOR 50 funds |
AGAINST 13 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Graham Smith Director Elections |
Board | For | FOR 50 funds |
AGAINST 13 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Michael Garnreiter Director Elections |
Board | For | FOR 50 funds |
AGAINST 13 funds |
| AXOS FINANCIAL INC. | November 14, 2024 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 9 funds |
| BAKKT HOLDINGS INC. | June 17, 2025 | To approve an amendment of the Company's Certificate of Incorporation to increase the number of authorized shares of Class A Common Stock. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BAKKT HOLDINGS INC. | June 17, 2025 | To approve an amendment to the Company's 2021 Omnibus Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BANNER CORP. | May 22, 2025 | Approval of the adoption of the Banner Corporation 2025 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 8 funds |
| BERRY CORP. | May 20, 2025 | Approve a non-binding resolution regarding the compensation of the Company's named executive officers for 2024 (say-on-pay). Say-on-Pay |
Board | Not determined | FOR 16 funds |
AGAINST 9 funds |
| BEYOND INC. | May 15, 2025 | The approval of an amendment and restatement of the Company's Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"). Compensation |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| BEYOND INC. | May 15, 2025 | The approval of an amendment to the 2005 Plan to increase the individual award limits for purposes of the issuance of the awards granted to Marcus A. Lemonis, the Company's Executive Chairman that exceed such limits (the "Contingent Awards"). Compensation |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| BGC GROUP INC. | September 16, 2024 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 9 funds |
| BIONTECH ADR | May 16, 2025 | Resolution on the approval of the Compensation Report Compensation |
Board | For | AGAINST 15 funds |
FOR 3 funds |
| BIRKENSTOCK HOLDING PLC | April 29, 2025 | To re-appoint Nisha Kumar as a Class II director of the Company. Director Elections |
Board | For | FOR 11 funds |
AGAINST 2 funds |
| BLINK CHARGING CO. | July 16, 2024 | Approve, on a non-binding advisory basis, the compensation paid to our executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 4 funds |
| BLUE OWL CAPITAL INC. | June 9, 2025 | Approval, by non-binding advisory basis, the compensation paid to our named executive officers for the 2024 fiscal year. Say-on-Pay |
Board | For | FOR 33 funds |
AGAINST 10 funds |
| BLUEBIRD BIO INC. | December 4, 2024 | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 3 funds |
| BLUEROCK HOMES TRUST INC | June 11, 2025 | The approval of the amendment and restatement of each of the 2022 Individuals Plan and the 2022 Entities Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| BM TECHNOLOGIES INC. | January 3, 2025 | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the Merger. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| BORR DRILLING LIMITED | May 21, 2025 | To re-elect Neil J. Glass as a Director of the Company. Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| BOUNDLESS BIO INC. | June 23, 2025 | Election of Director: Christine Brennan, Ph.D. Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| BOUNDLESS BIO INC. | June 23, 2025 | Election of Director: Nancy Whiting, Pharm.D. Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| BOX INC. | June 27, 2025 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 5,000,000 shares. Compensation |
Board | For | FOR 27 funds |
AGAINST 7 funds |
| BRIDGEBIO PHARMA INC. | June 20, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 34 funds |
AGAINST 9 funds |
| BROADWAY FINANCIAL CORP. | July 17, 2024 | To cast an advisory (non-binding) vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BROADWAY FINANCIAL CORP. | June 30, 2025 | To cast an advisory (non-binding) vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BROOKLINE BANCORP INC. | May 21, 2025 | A proposal to approve, on a non-binding advisory basis, the compensation that may become payable to the named executive officers of Brookline in connection with the Mergers (the "Brookline Merger-Related Compensation Proposal"). Say-on-Pay |
Board | For | FOR 23 funds |
AGAINST 8 funds |
| BUMBLE INC. | June 5, 2025 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 5 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Christopher Halmy as director. Director Elections |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect John Sievwright as director. Director Elections |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Robert Gillespie as director. Director Elections |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| C4 THERAPEUTICS INC. | June 18, 2025 | To approve an amendment to our Fifth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000. Capital Structure |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| CABALETTA BIO INC. | June 9, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 3 funds |
| CALIFORNIA WATER SERVICE GROUP | May 28, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 8 funds |
| CALIX INC. | May 8, 2025 | To approve the Calix, Inc. Fourth Amended and Restated 2019 Equity Incentive Award Plan. Compensation |
Board | For | FOR 23 funds |
AGAINST 7 funds |
| CALIX INC. | May 8, 2025 | To approve, on a non-binding, advisory basis, Calix's named executive officer compensation. Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 8 funds |
| CAPITAL BANCORP INC | May 15, 2025 | Proposal to approve the Capital Bancorp, Inc. 2017 Stock and Incentive Compensation Plan, as amended and restated, to increase the number of shares of common stock authorized for issuance under the plan by 520,000 shares, from 2,020,000 shares to 2,540,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| CASSAVA SCIENCES INC. | May 23, 2025 | To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 5 funds |
| CCC INTELLIGENT SOLUTIONS HOLDINGS INC. | May 22, 2025 | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers as set forth in the Proxy Statement for the Annual Meeting. Say-on-Pay |
Board | For | FOR 31 funds |
AGAINST 13 funds |
| CELCUITY INC. | May 13, 2025 | To approve, by a non-binding and advisory vote, compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 5 funds |
| CHEFS' WAREHOUSE INC. | May 9, 2025 | To approve an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| CHEWY | July 11, 2024 | To approve the Chewy, Inc. 2024 Omnibus Incentive Plan, including an increase in the number of shares reserved for issuance by 80,000,000 shares. Compensation |
Board | For | FOR 10 funds |
AGAINST 3 funds |
| CIBUS INC | May 22, 2025 | To approve the adoption of the Cibus, Inc. 2025 Employee Stock Purchase Plan. Capital Structure |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CIDARA THERAPEUTICS INC. | June 18, 2025 | Approval of an amendment to the Company's 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CIDARA THERAPEUTICS, INC. | July 18, 2024 | Approval of the Company's 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CISCO SYSTEMS INC. | December 9, 2024 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 83 funds |
AGAINST 17 funds |
| CITIZENS & NORTHERN CORP. | April 24, 2025 | TO APPROVE, IN AN ADVISORY (NON-BINDING) VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 3 funds |
| CITIZENS FINANCIAL GROUP INC. | April 24, 2025 | Advisory Vote on Executive Compensation. Say-on-Pay |
Board | For | FOR 64 funds |
AGAINST 15 funds |
| COCA-COLA CONSOLIDATED INC. | May 13, 2025 | Approval of the amendment to Coca-Cola Consolidated's Restated Certificate of Incorporation to effect a 10-for-1 forward stock split of Coca-Cola Consolidated Common Stock and Class B Common Stock and to proportionately increase the number of authorized shares of Coca-Cola Consolidated Common Stock and Class B Common Stock. Capital Structure |
Board | For | FOR 22 funds |
AGAINST 13 funds |
| COHERUS BIOSCIENCES INC. | June 11, 2025 | To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 5 funds |
| COMPOSECURE INC. | May 28, 2025 | A proposal to approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company's Common Stock from 250,000,000 shares to 1,000,000,000 shares. Capital Structure |
Board | For | FOR 12 funds |
AGAINST 2 funds |
| COOPER-STANDARD HOLDINGS INC. | May 15, 2025 | Advisory Vote on Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 6 funds |
| COTY INC. | November 7, 2024 | Approval, on an advisory (non-binding) basis, of the compensation of Coty Inc.'s named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 40 funds |
AGAINST 13 funds |
| CREATIVE MEDIA & COMMUNITY TRUST CORP. | August 1, 2024 | To consider and approve, by a non-binding advisory vote, the executive compensation for the fiscal year ended December 31, 2023, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | FOR 10 funds |
AGAINST 4 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025. Compensation |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Re-election of Douglas A. Treco, Ph.D. Director Elections |
Board | For | AGAINST 10 funds |
FOR 4 funds |
Page 1 of 5 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.